The drug from Xenoport (XNPT) is for moderate to severe Restless Leg Syndrome. This drug will compete with existing treatments IT is not clear if the drug presents an advantage compared to the existing treatments ...
XENOPORT (XNPT) IRRATIONAL EXUBERANCE ON HORIZANT.
Investors bid up shares of Xenoport (XNPT) by 56% on approval of Horizant.The company will have difficulty generating profits to support this huge stock move. We are now short from $10.18.For more details of the rationale ...
CHECK OUR PERFORMANCE
